Outdated risk assessment in a family with Duchenne dystrophy: Implications for duty to reassess
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received June 20, 2016
- Accepted in final form August 3, 2016
- First Published October 5, 2016.
Author Disclosures
- Lauren Bogue, MS and
- Sindhu Ramchandren, MD, MS
- Lauren Bogue, MS and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sindhu Ramchandren, MD, MS
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) NIH K23NS072279; Role: PI; Year(s): 09/01/2011- 08/31/2015
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Parent Project Muscular Dystrophy (L.B.), Hackensack, NJ; and Department of Neurology (L.B., S.R.), University of Michigan, Ann Arbor.
- Correspondence to Dr. Ramchandren: sindhur{at}umich.edu
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophyEvidence for failure of dystrophin production in dystrophin-competent myonucleiE. Pegoraro, R. N. Schimke, C. Garcia et al.Neurology, April 01, 1995 -
Article
WGS and RNA Studies Diagnose Noncoding DMD Variants in Males With High Creatine KinaseLeigh B. Waddell, Samantha J. Bryen, Beryl B. Cummings et al.Neurology: Genetics, January 29, 2021 -
Article
Relationships between DMD mutations and neurodevelopment in dystrophinopathyMathula Thangarajh, Jos Hendriksen, Michael P. McDermott et al.Neurology, October 08, 2019 -
Brief Communications
Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophyEdo M. Hoogerwaard, Ieke B. Ginjaar, Egbert Bakker et al.Neurology, December 27, 2005